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The cell wall mycolyl-arabinogalactan-peptidoglycan complex is
essential in mycobacterial species, such asMycobacterium tuberculo-
sis, and is the target of several anti-tubercular drugs. For instance,
ethambutol targets arabinogalactanbiosynthesis through inhibitionof
the arabinofuranosyltransferasesMt-EmbA andMt-EmbB. Following
a detailed bioinformatics analysis of genes surrounding the conserved
emb locus,wepresent the identificationandcharacterizationofanovel
arabinofuranosyltransferaseAftA (Rv3792). The enzyme catalyzes the
additionof the first key arabinofuranosyl residue fromthe sugardonor
-D-arabinofuranosyl-1-monophosphoryldecaprenol to the galactan
domain of the cell wall, thus “priming” the galactan for further elabo-
rationby thearabinofuranosyltransferases.BecauseaftA is anessential
gene inM. tuberculosis, we deleted its orthologue inCorynebacterium
glutamicum to produce a slow growing but viable mutant. Analysis of
its cell wall revealed the complete absence of arabinose resulting in a
truncatedcellwall structurepossessingonlyagalactancorewithacon-
comitant loss of cell wall-bound mycolates. Complementation of the
mutant was fully restored to the wild type phenotype by Cg-aftA. In
addition, by developing an in vitro assay using recombinant Esche-
richia coli expressingMt-aftA anduse of cellwall galactan as an accep-
tor, we demonstrated the transfer of arabinose from -D-arabino-
furanosyl-1-monophosphoryldecaprenol to galactan, and unlike the
Mt-Emb proteins, Mt-AftA was not inhibited by ethambutol. This
newly discovered glycosyltransferase represents an attractive drug tar-
get for further exploitation by chemotherapeutic intervention.
The Corynebacterianeae represent a distinct group within Gram-
positive bacteria, with prominent members being the human patho-
gens Mycobacterium tuberculosis, Mycobacterium leprae, and
Corynebacterium diphtheriae (1). In addition, nonpathogenic bacte-
ria belonging to this taxon, such as Corynebacterium glutamicum
and Corynebacterium efficiens, are used in the industrial production
of amino acids (2). A common feature of the Corynebacterianeae is
that they possess an unusual cell wall architecture (3–5). The cell
wall is dominated by an essential heteropolysaccharide, arabinoga-
lactan (AG),5 linked to both peptidoglycan and mycolic acids, form-
ing the mycolyl-arabinogalactan-peptidoglycan (mAGP) complex
(3–6). The biosynthesis of the arabinan domain of AG, which is
made up of 135-, 133-, and 132-glycosyl linkages, results
from the sequential addition of arabinofuranose (Araf ) residues
from the sugar donor -D-arabinofuranosyl-1-monophosphorylde-
caprenol (DPA) (7–9), by a set of unique arabinofuranosyltrans-
ferases termed the Emb proteins, of which three paralogues exist in
Mycobacterium avium (10) and M. tuberculosis (11).
The anti-tuberculosis drug ethambutol (EMB) specifically inhibits
AG biosynthesis (12), and the molecular target of EMB occupies the
embCAB locus in M. tuberculosis (11). Upon individual disruption of
embC, embA, and embB in Mycobacterium smegmatis, the resultant
mutants are viable (13, 14). However, the crucial terminal Ara6 motif,
which is the structural motif for mycolylation in AG (5), is altered in
both the Ms-embA and Ms-embB mutants (13). These results suggest
that EmbA and EmbB are involved in the formation of the terminal Ara6
motif in AG and also presumably compensated for each other in the
respective Ms-embA and Ms-embB mutants, whereas Ms-embC is
probably involved in the formation of the arabinan domains of
lipoarabinomannan (LAM) (14). This is in agreement with the initial
studies of the Ms-embC mutant (14) and recent findings that indicate
when pointmutationswere re-introduced into theMs-embCmutant on
amulticopy plasmid expressing themutant allele, a truncated LAMwas
synthesized, which retained the basic glycosyl linkage profile of LAM
(15). However, attempts to obtain deletion mutants of embA and embB
in M. tuberculosis or embAB in M. smegmatis have proved unsuccess-
ful,6 presumably because of the essentiality of the cell wall mAGP in
these bacteria (16–19). In contrast, C. glutamicum has proven useful in
the study of orthologousM. tuberculosis genes essential for cell viability.
For instance, Cg-pks has been shown to be the keyClaisen condensation
enzyme involved in mycolic acid biosynthesis through the construction
of a deletion mutant of C. glutamicum and its complementation with
the Mt-pks13 orthologue (19, 20).
In a recent study (6), deletion of the single Cg-emb orthologue in
C. glutamicum resulted in a slow growing yet viable mutant that syn-
thesized a novel truncated AG structure possessing a galactan core and
only t-Araf residues. Moreover, partial acid hydrolysis and matrix-
assisted laser desorption ionization time-of-flight analysis identified the
precise location of the three singular t-Araf residues attached to the
galactan core on the 8th, 10th, and 12th galactofuranose (Galf) residue,
thus representing the anchor points of the intact arabinan domains of
AG (6). Treatment of C. glutamicum with EMB resulted in an identical
phenotype comparable with theC. glutamicumembmutant (6). Thus,
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in contrast to the disruption of Ms-embA and Ms-embB, deletion of
Cg-emb leads to an almost entire absence of arabinose in the cell wall,
apart from specific t-Araf residues that are directly linked to the galactan
backbone. This suggested the presence of a novel enzyme responsible
for “priming” the galactan domain for further elaboration by the Emb
proteins, resulting in the final maturation of the native AG polysaccha-
ride. It is the aim of this study to identify this novel arabinofuranosyl-
transferase, which catalyzes the addition of the first key Araf residues to
the galactan domain of AG.
EXPERIMENTAL PROCEDURES
Strains and Culture Conditions—M. tuberculosis H37Rv DNA was
obtained from the Tuberculosis Research Material Contract (National
Institutes of Health) at Colorado State University. C. glutamicum
ATCC 13032 (the wild type strain, and in the remainder of the text it is
referred to as C. glutamicum) and Escherichia coli DH5MCR were
grown in Luria-Bertani broth (LB; Difco) at 30 and 37 °C, respectively.
The mutants generated in this study were grown on complex medium
BHIS (21). Kanamycin and ampicillin were used at a concentration of 50
g/ml. The minimal medium CGXII was used for C. glutamicum (21).
Samples for lipid analyses were prepared by harvesting cells at an
absorbance of 10–15, followed by a saline wash and freeze drying. Cul-
tivation of C. glutamicum aftA for lipid and cell wall analysis required
two pre-cultures. First, a 5-ml BHIS culture was grown for 8 h, which
was then used to inoculate a 50-ml BHIS culture for 15 h. This was then
used to inoculate a 100-ml BHIS culture to an absorbance of 1, which
was harvested after reaching absorbance of 3.
Construction of Plasmids and Strains—The vectors made were
pET23b-Mt-aftA (Rv3792), pEKEx2Cg-aftA (NCgl0185), pEKEx2Mt-
aftA, and pK19mobsacBaftA, with the gene number of the M. tuber-
culosis and C. glutamicum aftA orthologue added in parentheses. To
construct the E. coli expression vector pET23b-Mt-aftA, the prim-
er pair 5-GATCGATCCATATGCCGAGCAGACGCAAAAGCCCC-
CAATTC-3 and 5-GATCGATCAAGCTTCGCGCTCTCCTGCGG-
CTTGCGGATGGC-3 was used with the restriction sites NdeI and
HindIII underlined, withM. tuberculosis H37Rv chromosomal DNA as a
template. The purified PCR fragmentwas ligatedwith accordingly digested
pET23b (Novagen). To overexpress C. glutamicum aftA, the primer pair
5-TCCCCCGGGAAGGAGATATAGATATGATTAACACCTCTGA-
AGATGAAG-3 and 5-TCCCCCGGGTTACTCATTGTGCGTTAC-
CACCAC-3 was used to amplify C. glutamicum aftA, which was ligated
with SmaI-cleaved pEKEx2 to generate pEKEx2Cg-aftA. Similarly, primer
pairs 5-CAGGATCCAAGGAGATATAGATATGCCGAGCAGACG-
CAAAAG-3and5-CAGGATCCCCATCCGCGCTCTCCTGCGGCT-
TGC-3were used to clone M. tuberculosis aftA into the BamHI site of
pEKEx2. To construct the deletion vector pK19mobsacBaftA, cross-
over PCR was applied with primer pairs AB (A, 5-CGTGGATCCGGT-
GCC-3; B, 5-CCCATCCACTAAACTTAAACATTCAGAGGTGTT-
AATCAT-3) andCD (C, 5-TGTTTAAGTTTAGTGGATGGGGTGG-
GACCTTTCGTGGTGGTAACG-3; D, 5-GGCGTCCGTACTGTC-
CAG-3) andC. glutamicum genomic DNA as template. Both PCR prod-
ucts were used in a second PCR with primer pairs AD to generate a
fragment consisting of sequences adjacent to Cg-aftA, which was blunt
end-ligated with SmaI-cleaved pK19mobsacB. All plasmids were finally
confirmed by sequencing. The chromosomal deletion of Cg-aftA was
performed as described using two rounds of positive selection (22), and
its successful deletion was verified by use of different primer pairs. Plas-
mid pET23b-Mt-aftA was used to transform chemically competent
cells of E. coli C43 (DE3) to ampicillin resistance (100 g/ml), and
pEKEx2Cg-aftA was introduced into C. glutamicum aftA by electro-
poration with selection to kanamycin resistance (25 g/ml).
Extraction and Analysis of Cell Wall-bound Mycolic Acids—Cells
were grown as described above, harvested, washed, and freeze-dried.
Cells (100 mg) were extracted by two consecutive extractions with 2 ml
of CHCl3/CH3OH/H2O (10:10:3, v/v) for 3 h at 50 °C. The bound lipids
from the delipidated extracts or purified cell walls (see below) were
released by the addition of 5% aqueous solution of tetrabutylammo-
nium hydroxide, followed by overnight incubation at 100 °C, meth-
ylated as described previously (6), and analyzed by TLC using known
standards (6).
Isolation of themAGPComplex—The thawed cells were resuspended
in phosphate-buffered saline containing 2% Triton X-100 (pH 7.2), dis-
rupted by sonication, and centrifuged at 27,000  g (4, 6, 23). The
pelleted material was extracted three times with 2% SDS in phosphate-
FIGURE 1. Comparison of the aftA locus within the Corynebacterianeae. A, the locus
inM. tuberculosis (M. tub.) consistsofaftAwith its twoupstreamgenesRv3790andRv3791
leading to the formationofDPA (24, 25). DownstreamofaftA thegenes embC, embA, and
embB are located encoding known arabinofuranosyltransferases (11). The organization
of Rv3790, Rv3791, aftA, and embC is retained in a number of Corynebacterianeae indic-
ative of a basic functional unit. In N. farcinica (N. far.), a glycosyltransferase of unknown
function is located between aftA and embC. In C. jeikeium (C. jek.), Rv3790 and Rv3791 are
clustered but are located at another locus. The abbreviations used are as follows:M. bov.,
M. bovis;M. av. p.,M. avium paratuberculosis;M. lep.,M. leprae; C. eff., C. efficiens; C. dip.,
C. diphtheriae; andC. glu., C. glutamicum. B, topology of AftA and EmbCofM. tuberculosis.
The topology is predictedusingdense alignment surface (30). AftA spans themembrane
11 times and EmbC 13 times, and both have a C-terminal extension located in the
periplasm covering about one-third of the protein. The star indicates a highly conserved
region that resides in theperiplasmic loopand isprobably concernedwithglycosyltrans-
ferase activity. C, partial sequence comparison of region I of AftA proteins (star in B),
indicating their high degree of identity. The conserved negative residues possibly
involved in glycosyltransferase activity are shaded in gray. The abbreviations are as
above includingMycobacteriummarinum (M. mar.).
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buffered saline at 95 °C for 1 h to remove associated proteins, succes-
sively washed with water, 80% (v/v) acetone in water, and acetone,
and finally lyophilized to yield a highly purified cell wall preparation
(4, 6, 23).
Glycosyl Composition and Linkage Analysis of Cell Walls by Alditol
Acetates—Cell wall preparations were hydrolyzed using 2 M trifluoro-
acetic acid, reduced with NaB2H4, and the resultant alditols per-
O-acetylated and examined by gas chromatography (GC) as described
previously (4, 6, 23). Cell wall preparations were per-O-methylated
using dimethyl sulfinyl carbanion as described previously (4, 6, 23). The
per-O-methylated cell walls were hydrolyzed using 2 M trifluoroacetic
acid, reduced with NaB2H4, per-O-acetylated, and examined by gas
chromatography/mass spectrometry (GC/MS) as described previously
(4, 6, 23). Analysis of alditol acetate sugar derivatives was performed on
a CE Instruments ThermoQuest Trace GC 2000. Samples were injected
in the splitless mode. The column used was a DB225 (Supelco). The
oven was programmed to hold at an isothermal temperature of 275 °C
for a run time of 15 min (6). GC/MS was carried out on a Finnigan
Polaris/GCQ PlusTM. The column used was a BPX5 (Supelco).
DPA and Cg-Emb Biosynthetic Activity within Membrane Prepara-
tions of C. glutamicum and C. glutamicum aftA—Membranes from
C. glutamicum and C. glutamicum aftA were prepared as described
previously to determine DPA biosynthetic activity (24, 25). Membrane
protein (1 mg) was added to 5-phospho[14C]ribofuranose pyrophos-
phate (2 106 cpm), 50 g of decaprenol monophosphate, 60 M ATP,
0.5mMNADP in 50mMMOPS (pH 7.9), 5mM-mercaptoethanol, and
10 mM MgCl2 (buffer A) to a final volume of 160 l. The reaction
mixture was incubated for 1 h at 37 °C and stopped by the addition of 3
ml of CHCl3/CH3OH (2:1, v/v). Radiolabeled lipid linked sugars were
extracted, as described previously, prior to scintillation counting and
subjected to TLC using silica gel plates (5735 Silica Gel 60F254, Merck)
in CHCl3/CH3OH/H2O/NH4OH (65:25:3.6:0.5, v/v) with reaction
products visualized by autoradiography (24, 25). Analysis of Cg-Emb
activity was determined using the synthetic -D-Araf-(135)--D-Araf-
O-C10:1 acceptor in a cell-free assay as described previously (8).
Expression and Analysis of Mt-aftA Gene Product—For expression
studies, E. coli (C43) was transformed with pET23b-Mt-aftA and cul-
tured in Terrific Broth at 37 °C until an absorbance of 0.5, followed by
the addition of 1 mM isopropyl 1-thio--D-galactopyranoside and fur-
ther incubation for 12 h at 16 °C. Cells were harvested by centrifugation
FIGURE 2. Construction and characteristics of C. glutamicum aftA. A, illustrated is
Cg-aftAwith its adjacent genesNCgl0186 andCg-emb and the strategy todelete Cg-aftA
by using the deletion vector pK19mobsacBaftA. This vector carries 18 nucleotides of
the 5-end of Cg-aftA and 36 nucleotides of its 3-end, thereby enabling the in-frame
deletionof almost theentireCg-aftAgene. ThearrowsmarkedP2 locate theprimersused
for the PCR analysis to confirm the absence of Cg-aftA. Primers P1 were used to detect
NCgl0187 and NCg10186, the orthologue of Rv3790 and Rv3791, and P3 to detect Cg-
emb. Distances are not drawn to scale. The results of the PCR analysis are shown on the
right, whereNCg10187 andNCg10186mark the result obtainedwith primers P1, Cg-aftA
with P2, and Cg-emb with P3. Samples were applied pairwise with the PCR product
obtained from thewild type applied in the left lane and that of thedeletionmutant in the
right lane. Stmarks the standard, where the arrowheads are located at 10, 3, 2, 1, and 0.5
kb, respectively. B, the consequences of Cg-aftA deletion on growth in richmedium BHI.
GrowthofC. glutamicum (F),C. glutamicumaftA (), aswell as the same strain express-
ing plasmid encoded Cg-aftA (f), Mt-aftA (Œ), and Cg-emb () is shown. C, conse-
quences of Cg-aftA deletion on the same medium as in B but supplemented with 0.5 M
sorbitol for osmotic stabilization. Symbols are same as in B.
FIGURE 3. Analysis of cell wall-bound CMAMEs from delipidated cells of C. glutami-
cum, C. glutamicun aftA, and C. glutamicum aftA pEKEx2aftA. Lane 1, C. glutami-
cum; lane 2, C. glutamicum aftA; lane 3, C. glutamicum aftA pEKEx2aftA. The bound
corynomycolic acids from the delipidated extracts or purified cell walls were released by
the addition of tetrabutylammonium hydroxide at 100 °C overnight and methylated as
described under “Experimental Procedures.” An aliquot from each strain was subjected
to TLC using silica gel plates (5735 Silica Gel 60F254, Merck), and developed in petroleum
ether/acetone (95:5, v/v) and charred using 5% molybdophosphoric acid in ethanol at
100 °C to reveal CMAMEs and compared with known standards (6, 19).
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at 5000 rpm, and the resulting pellet was resuspended in buffer A.
Resuspended cells were sonicated and centrifuged at 23,000 g for 20
min at 4 °C, and the resulting supernatant was recentrifuged at
100,000  g for 90 min at 4 °C to isolate cell membranes that were
collected and concentrated to a protein concentration of 15–20 mg/ml.
Decaprenol phospho[14C]arabinose (100,000 cpm (45 M) prepared
as described previously (9, 26) and stored in CHCl3/CH3OH, 2:1 (v/v))
was dried under a streamof argon in amicrocentrifuge tube (1.5ml) and
placed in a vacuumdesiccator for 15min to remove any residual solvent.
The dried decaprenol phospho[14C]arabinose was then resuspended in
30 l of buffer A supplemented with 10% IgePal CA-630 (Sigma). An
aliquot of this decaprenol phospho[14C]arabinose solution (10,000 cpm,
4.5 M, 3 l) was added to the remaining constituents of the assay,
which included 1mg ofmembranes containingMt-AftA and increasing
FIGURE4.Glycosyl compositional andglycosyl linkageanalysis of cellwalls ofC. glutamicum (A),C. glutamicumaftA (B), andC. glutamicumaftApEKEx2aftA (C). Samples
of purified cell walls were hydrolyzed using 2 M trifluoroacetic acid, reduced, per-O-acetylated, and subjected to GC as described under “Experimental Procedures.” Alditol acetate
standards (Supelco) of Rha, Ara, and Gal were analyzedwith retention times of 6, 7 and 10.1min, respectively. Cell walls were per-O-methylated, hydrolyzed using 2 M trifluoroacetic
acid, reduced, and per-O-acetylated. The resulting partially per-O-methylated and per-O-acetylated glycosyl derivatives were analyzed by GC/MS as described previously (4, 6, 23).
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amounts of purified cell wall galactan polymer (0.1–1.0 mg, which rep-
resents0.015–0.15mM galactan acceptor (6, 27, 28)) fromC. glutami-
cumaftA in buffer A to a final volume of 300 l. The reaction mixture
was incubated for 1 h at 37 °C, and the pellet was recovered following
centrifugation at 18,000 g. The pellet was washed twice with 1 ml of
buffer A containing 1% IgePal CA-630 and further washed with 1 ml of
CHCl3/CH3OH (2:1, v/v) until the radioactivity was recorded as back-
ground in the final supernatant washes (less than 30 cpm). The pellet
was finally resuspended in buffer A and transferred to a scintillation vial,
and 10 ml of EcoScint was added, and the amount of [14C]arabinose
incorporation into cell wall galactan was measured by scintillation
counting.
Analysis of Mt-AftA Assay Product—The basic assay was repeated
five times as described above, but using nonradiolabeled DPA (200 g,
0.75 mM) (9, 26), and 1 mg of cell wall galactan polymer prepared from
C. glutamicum aftA. Following an initial incubation at 37 °C for 1 h,
the assay was replenishedwith freshmembranes containingMt-AftA (1
mg) and re-incubated for 1 h at 37 °C with the entire process repeated
three timeswith the addition of freshmembranes. The reactionmixture
was processed as described above using two 1% IgePal CA-630 deter-
gent washes in buffer A (1 ml) and five CHCl3/CH3OH (1 ml, 2:1, v/v)
extractions followed by centrifugation at 18,000  g. The recovered
pellets were pooled, per-O-methylated, hydrolyzed using 2 M trifluoro-
acetic acid, reduced with NaB2H4, per-O-acetylated, and analyzed by
GC/MS as described previously (6).
RESULTS
Genome Comparison of the Emb Locus—Based on our previous
observation that C. glutamicum emb possessed no known arabino-
furanosyltransferase activity yet contained single t-Araf units attached
to the galactan core (6), we analyzed a 14-kb chromosomal region ofM.
tuberculosis encompassing embC, embA, and embB in detail and com-
pared it with that of other Corynebacterianeae (Fig. 1A). This region
includes the recently discovered decaprenylphosphoryl-5-phosphori-
bose (DPPR) epimerizing enzymes encoded by Rv3790 and Rv3791,
which eventually provide Araf units from the sugar donor DPA (8, 24,
25, 29). These genes are followed by Rv3792which is adjacent to embC.
This particular region consisting of four genes is syntenic with regions
inMycobacterium bovis, M. avium subsp. paratuberculosis, andM. lep-
rae as well as with those of C. efficiens, C. diphtheriae, and C. glutami-
cum. In addition, Nocardia farcinica also shows ample synteny to the
M. tuberculosis gene locus, as well as Corynebacterium jeikeium, indi-
cating a fundamental function of Rv3792. Based on the results described
below, the Rv3792 gene and its orthologues was designated aftA (acro-
nym for arabinofuranosyltransferase A).
M. tuberculosis aftA is predicted to encode a membrane protein of
643 amino acid residues. The predicted topology of the N-terminal
region (residues 1–459) contains several hydrophobic segments based
on dense alignment surface analysis (30), which probably form 11 trans-
membrane-spanning helixes, whereas the C-terminal region (residues
460–643) is predicted to be directed toward the periplasm. This
domain organization and localization somewhat resemble that of EmbC
(Fig. 1B). Nevertheless, the AftA proteins show no significant sequence
similarity to the Embproteins, and unlike the Embproteins, they are not
included in the CAZy data base of glycosyltransferases (31). However,
the similarity of the AftA proteins among each other is very high over
their entire sequence. Even for the most distant pairs, M. tuberculosis
and C. diphtheriae, there is still 35.1% identity spanning 555 amino acid
residues. The three regions of maximal similarity extend from 111 to
191 (I), 474 to 498 (II), and 516 to 551 (III) (amino acid residues of M.
tuberculosis AftA). These regions contain several strictly conserved
acidic and polar side chains as exemplified for part of region I of AftA
(Fig. 1C), which are also known to play roles of general base and nucleo-
philic residues in glycosyl hydrolysis (31). Interestingly, region I
(marked by a star in Fig. 1B) contains a conserved stretch of amino acids
similar to that of the GT-C motif in EmbC, which is located in a
periplasmic loop between membrane-spanning domains 3 and 4 (15).
Taken together, the structural features of AftA aswell as the localization
of aftAwithin the gene cluster involved in arabinan biosynthesis suggest
that AftA represents a putative glycosyltransferase involved in arabinan
polymerization.
Construction and Growth of C. glutamicum aftA—Despite the fact
that Rv3792 is essential for M. tuberculosis (32), we attempted to de-
lete its orthologue in C. glutamicum. The nonreplicative plasmid
pK19mobsacBaftA was constructed carrying sequences adjacent to
Cg-aftA. The vector was introduced into C. glutamicum, and in several
electroporation assays kanamycin-resistant clones were obtained, indi-
cating integration of pK19mobsacBaftA into the genome by homolo-
gous recombination (Fig. 2A). The sacB gene enables positive selection
of a second homologous recombination event that can result either in
the original wild type genomic organization or in clones deleted of aftA
(20). More than 200 clones were obtained after 2–4 days and analyzed
by PCR, but all were wild type, illustrating a strong disadvantage of aftA
deletion. We continued with this analysis to eventually obtain in three
independent approaches three rough textured colonies appearing after
about 15 days. These were shown by PCR to have aftA deleted, whereas
inspection of the adjacent C. glutamicum open reading frames resulted
in identical PCR products to that of controls derived from the wild type
(see Fig. 2A).
Growth of C. glutamicum aftA in liquid brain-heart-infusion
medium is shown in Fig. 2B. The mutant was almost unable to grow on
this medium, whereas the presence of plasmid-encoded Cg-aftA
(pEKEx2Cg-aftA) almost fully restored growth. Also, upon comple-
mentation of the mutant with Mt-aftA (pEKEx2Mt-aftA), growth res-
toration was obtained, albeit somewhat reduced, whichmight be due to
the biased codon usage of M. tuberculosis. Transformation of C. glu-
tamicum aftA with pEKEx2emb (6) did not restore the growth defect,
showing that overexpression of Cg-emb is unable to substitute Cg-aftA,
thus confirming the unique specificity of both AftA and Emb. The iden-
FIGURE 5. Production of DPA (A) and Cg-Emb activity (B) within membrane prepara-
tionsofC.glutamicumandC.glutamicumaftA.Radiolabeled lipid-linkedsugars (A)were
extracted following incubation with membranes and 5-phospho[14C]ribofuranose pyro-
phosphate, counted, and subjected to TLC using silica gel plates (5735 Silica Gel 60F254,
Merck) in CHCl3/CH3OH/H2O/NH4OH (65:25:3.6:0.5, v/v) with reaction products (DPA and
DPPR) visualized by autoradiography. Lane 1, C. glutamicum; lane 2, C. glutamicum aftA.
Cg-Emb activity (B) was determined using the synthetic -D-Araf-(135)--D-Araf-O-C10:1
acceptor in a cell-free assay as described previously (8). The product X (-D-[14C]Araf-(132/
5)--D-Araf-(135)--D-Araf-O-C10:1)wasresuspendedprior toscintillationcountingandsub-
jected to TLC using silica gel plates (5735 silica gel 60F254, Merck) in CHCl3:CH3OH:H2O (65:
25:4, v/v) with the reaction products visualized by autoradiography. Lane 1, control, no
membranes; lane 2,C. glutamicum; lane 3,C. glutamicumaftA.
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tical strains were also grown on the same medium as before (brain-
heart-infusion) but osmotically stabilized with 0.5 M sorbitol (Fig. 2C).
Surprisingly, under these conditions, substantial growth was possible
for C. glutamicum aftA, which is presumably indicative of sorbitol
stabilizing the cell wall mutant. On this medium the growth rate
obtained for the wild typewas 0.66 h1 with a final absorbance of 17 and
that for the deletion mutant was 0.31 h1 with a final absorbance of 15.
Cell Wall-bound Corynomycolic Acid and Glycosyl Compositional
and Linkage Analysis of Cell Walls—To relate the above growth pheno-
typic changes ofC. glutamicumaftA to its cellular composition,C. glu-
tamicum aftA and its complemented strain along with C. glutamicum
were analyzed for arabinogalactan-esterified corynomycolic acids. C.
glutamicum exhibited the known profile of corynomycolic acid methyl
esters (CMAMEs) (Fig. 3, lane 1), whereas cell wall-bound corynomy-
colic acids were absent in C. glutamicum aftA (Fig. 3, lane 2). The
complementation of C. glutamicum aftA with Cg-aftA (Fig. 3, lane 3)
led to the restoration of cell wall-bound corynomycolic acids. These
results suggest that Cg-aftA was involved in a key aspect of arabinan
biosynthesis, whereby deletion perturbs tethering of corynomycolic
acids to AG. Analysis of alditol acetate derivatives prepared from puri-
fied cell walls of C. glutamicum by GC revealed the sugar composition
rhamnose (Rha), Ara, and Gal (Fig. 4A) (6). GC analysis of alditol ace-
tates prepared from C. glutamicum aftA (Fig. 4B) revealed a total loss
of cell wall arabinose, which was restored upon complementation with
plasmid pEKEx2Cg-aftA (Fig. 4C). GC/MS of per-O-methylated alditol
acetate derivatives of C. glutamicum, C. glutamicum aftA, and C. glu-
tamicumaftA pEKEx2Cg-aftA is shown in Fig. 4,A–C. Apart from the
presence of 2,5-Araf and t-Rhap associated with the arabinan domain of
AG inC. glutamicum, other glycosidic linkages are comparable between
M. tuberculosis (4, 33) and C. glutamicum (6, 27, 33) and include t-Araf,
2-Araf, 5-Araf, 3,5-Araf, 4-Rhap, t-Galf, 5-Galf, 6-Galf, and 5,6-Galf (Fig.
4A). As expected, C. glutamicum aftA was devoid of t-Araf, t-Rhap,
2-Araf, 5-Araf, 3,5-Araf, and 2,5-Araf, whereas the galactan domain
(apart from the 5,6-Galf branching residues resulting fromarabinan side
chains) was completely unaffected by the deletion of Cg-aftA and con-
tained 4-Rhap, t-Galf, 5-Galf, and 6-Galf (Fig. 4B). Complementation of
C. glutamicum aftA with plasmid pEKEx2Cg-aftA restored the glyco-
syl linkage profile to that of C. glutamicum (Fig. 4, A and C). The previ-
ous deletion of emb in C. glutamicum and chemical analysis of the cell
wall revealed a drastically truncatedAG structure possessing only t-Araf
residues and an unaltered galactan domain (6). Thus, the results indi-
cate that aftA represents a putative arabinofuranosyltransferase respon-
sible for priming the galactan domain with Araf residues for subsequent
elaboration by Emb proteins.
Analysis of DPA Synthesis and Cg-Emb Activity—In order to ensure
that in C. glutamicum aftA the biosynthesis of DPA is not reduced
thereby disabling Araf delivery to the cell wall, we examined DPA
and DPPR biosynthesis. Based on previous studies (24, 25) using
5-phospho[14C]ribofuranose pyrophosphate and decaprenol phosphate
to monitor DPA formation, membranes were prepared from C. glutami-
cum andC. glutamicumaftA. Both preparations afforded DPA synthesis
(Fig. 5A), demonstrating that therewasno reducedability ofC. glutamicum
aftA to synthesize DPA. In fact, an accumulation of DPA and DPPR was
FIGURE 6. Expression and functional characterization of recombinant Mt-aftA.
A, expression ofMt-aftAwithin E. coli (C43)membranes was confirmed by SDS-PAGE analy-
sis.Lane1,molecularmassstandards (kDa); lane2,E. coli (C43)uninducedmembranes; lane3,
E. coli (C43) membranes expressing Mt-AftA. B, the data illustrate an increase in [14C]arabi-
nose incorporation into cell wall galactan from decaprenol phospho[14C]arabinose with a
fixed amount of E. coli (C43) membranes containing recombinant Mt-AftA (1mg/ml). Back-
ground counts (less than 30 cpm) have been subtracted to give a final value for [14C]arabi-
nose incorporationwith 0.1mg (lane 1), 0.25mg (lane 2), 0.5mg (lane 3), and 1.0mg (lane 4)
of cell wall galactan. Lane 5 represents the same reaction as lane 4 supplemented with
100 g/ml ethambutol. In addition, control assays were performed with membranes
prepared fromuninduced E. coli or E. coli harboring empty pET23b also resulted in back-
ground counts (less than 30 cpm) for the [14C]Araf incorporation from decaprenol
phospho[14C]arabinose in the presence of increasing cell wall galactan acceptor. C, the
reaction identical to that described above (B, lane 4) was performed but using nonradio-
labeled DPA. After incubation the reaction product was extracted, per-O-methylated,
hydrolyzed, reduced with NaB2H4, per-O-acetylated, and analyzed by GC/MS as
described under “Experimental Procedures.”
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evident in C. glutamicum aftA (75 and 80%, respectively) as compared
with C. glutamicum. Using endogenous acceptor andmembrane prepara-
tions of either C. glutamicum or C. glutamicum aftA, we observed no
apparent Emb transferase activity with C. glutamicum aftA compared
with a sustained level of activitywithC. glutamicum (data not shown), thus
suggesting that the endogenous acceptor from C. glutamicum aftA
requires primingwithAraf residues. In contrast, use of the synthetic accep-
tor -D-Araf-(135)--D-Araf-O-C10:1 (8, 9) resulted in a significant trans-
fer of [14C]arabinose fromdecaprenol phospho[14C]arabinose (8) affording
an organic soluble trisaccharide product with membrane preparations
from both strains (Fig. 5B). Thus, Emb is fully functional inC. glutamicum
aftA, asdemonstratedaboveandby theearliergeneticexperiments (Fig. 2,
B andC). Furthermore, these results followourhypothesis that the galactan
domain of AG requires priming by the addition of a single Araf unit to the
C-5 OH of a (136)-linked Galf sugar for recognition and further exten-
sion by the Emb proteins.
Cloning and Functional Characterization of Recombinant Mt-
aftA—By using M. tuberculosis H37Rv chromosomal DNA as a tem-
plate, Mt-aftA was amplified by PCR, and the purified fragment was
ligatedwith pET23b enabling expression ofHis6-taggedMt-aftA.Mem-
FIGURE7.Proposedbiosyntheticpathway lead-
ing to arabinan formation in M. tuberculosis
AG.
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branes were prepared from E. coli (C43) pET23b-Mt-aftA and analyzed
by SDS-PAGE revealing a weakly staining protein band with an appar-
ent molecular mass of 69.5 kDa, which was absent in uninduced cul-
tures, and a size predicted for Mt-His6AftA (Fig. 6A). According to the
current data, the reaction catalyzed by Mt-AftA is the transfer of Araf
from DPA to galactan. Therefore, an arabinose-free cell wall galactan
acceptor was prepared from C. glutamicum aftA and incubated with
the E. colimembrane preparation expressing His6-taggedMt-aftA. Fol-
lowing incubation, the residual decaprenol phospho[14C]arabinose sub-
strate was removed from the cell wall galactan by detergent and several
repeated extractions using CHCl3/CH3OH (2:1, v/v). The remaining
insoluble cell wall core was then subjected to scintillation counting
revealing an increased amount of [14C]Araf incorporation in the pres-
ence of increasing amounts of cell wall galactan acceptor (Fig. 6B). Sur-
prisingly, a 10-fold increase in cell wall galactan acceptor resulted in
only a 3-fold increase in transferase activity. This poor turnover is pre-
sumably because of the inefficiency of the assay, which utilizes insoluble
cell wall galactan as an acceptor. In addition, the activity of Mt-AftA
remained unaffected in the presence of 100 g/ml EMB (Fig. 6B), a
known inhibitor of Cg-Emb (6), Mt-EmbA, and Mt-EmbB (11).
The conversion of the galactan acceptor to a sugar polymer contain-
ing t-Araf units was further confirmed by glycosyl linkage analysis of the
enzymatic reaction product (Fig. 6C). The newly synthesized product of
several scaled up nonradiolabeled reactions was recovered, per-O-
methylated, and derivatized to alditol acetates, which were analyzed by
GC/MS.The linkages identified included those associatedwith the orig-
inal cell wall galactan acceptor (Fig. 4B) plus the appearance of t-Araf,
and as a result the branched 5,6-Galf residues (Fig. 6C).
Thus, our results describe the first report of a novel EMB-resistant
arabinofuranosyltransferase, AftA, as the key initial glycosyltransferase
involved in cell wall arabinan biosynthesis in Corynebacterianeae (Fig.
7) likeM. tuberculosis and C. glutamicum.
DISCUSSION
The mAGP represents one of the most important cell wall compo-
nents of the Corynebacterianeae and is essential for the viability of M.
tuberculosis (16–19). It is therefore not surprising that one of the most
effective anti-mycobacterial drugs, EMB, targets its biosynthesis. How-
ever, the emergence of multidrug-resistant tuberculosis has accelerated
the need to discover new drug targets (34).We previously hypothesized
the presence of a new priming enzyme that would link the initial Araf
unit with theC-5OHof a(136)-linkedGalf of a presynthesized galac-
tan core (6). This was derived from a thorough analysis of a C. glutami-
cum mutant deleted of its single arabinofuranosyltransferase Emb (6),
which still synthesizes a linear galactan extending from the reducing
Rha with single t-Araf residues attached to the 8th, 10th, and 12th Galf
residue. Apparently, these specific Araf residues serve for recognition
and extension by the known Emb proteins resulting in the formation of
the mature arabinan chains (6, 10, 11).
The in vivo analysis of C. glutamicum aftA, as well as the in vitro
study with the AftA protein of M. tuberculosis, identifies a bona fide
arabinofuranosyltransferase. In principle, the absence of Araf residues
inC. glutamicumaftA could be due to the unavailability of precursors,
as we demonstrated previously with a C. glutamicummutant devoid of
the polyprenyl transferase (UbiA) activity involved in the synthesis of
DPA (6). However, we established that DPA biosynthesis was main-
tained in C. glutamicum aftA, as well as Emb-catalyzed arabinan bio-
synthesis in vitro. This, together with our previous study on C. glutami-
cumemb, shows thatAftA functions to link the first Araf residue to the
cell wall galactan core. More importantly, the recombinant Mt-AftA
transferred Araf units from DPA to a cell wall galactan core acceptor
in vitro, thus further confirming the unique activity of the enzyme.
Although both Emb and AftA are arabinofuranosyltransferases, the
proteins cannot functionally replace each other. Thus, despite some
functional relationship, both glycosyltransferases have inherent specific
features as is also evident from the insensitivity ofMt-AftA andCg-AftA
toward EMB, whereas the single Cg-Emb (6, 35) and Mt-Emb proteins
are sensitive toward EMB (11).
The discovery of AftA sheds new light on the key arabinofuranosyl-
transferases that build the arabinan domain,which is typical forCoryne-
bacterianeae. An elementary structure of this sugar polymer is apparent
inC. glutamicum, and this bacterium has proven useful for a number of
studies on mAGP biosynthesis (6, 19, 20). It represents the archetype of
the Corynebacterianeae and has a low frequency of structural alter-
ations as manifested, for instance in a low number of gene duplications
(36). Corynebacterium species have only one emb gene, whereasMyco-
bacterium species have up to three. Nevertheless, the glycosidic linkage
analysis of C. glutamicum AG shows that 2-Araf, 5-Araf, and 3,5-Araf
linkages are present, which are analogous to those found in theAGofM.
tuberculosis (4). Furthermore, in C. diphtheriae and C. glutamicum 2,5-
Araf linkages are also evident (6, 37). This suggests the possibility that
one single Emb glycosyltransferase enables the formation of different
linkage types, a feature reminiscent of the bi-functional galactofurano-
syltransferase (GlfT) ofM. tuberculosis that produces alternating 5-Galf
and 6-Galf linkages within the galactan core of AG (38, 39). The high
syntenies of theM. tuberculosis Rv3790, Rv3791, aftA, and embC to the
maps of all other Mycobacterium and Corynebacterium species are in
agreement with this view (Fig. 1A). Also in N. farcinica this general
organization is retainedwith an additionalmembrane protein-encoding
gene. This largely retained organization, as well as the separation of the
paralogous embAB genes inM. leprae andM. avium subsp. paratuber-
culosis is indicative of an ancient core function of Rv3790, Rv3791, aftA,
and embC within the Corynebacterianeae involved in the synthesis of
Araf donors and their use to assemble a basic periplasmic arabinan
domain that serves as a scaffold to tie mycolic acids. The identification
of new cell wall biosynthetic drug targets is of great importance, espe-
cially with the emergence of multidrug-resistant tuberculosis. This
newly discovered DPA-dependent arabinofuranosyltransferase repre-
sents a promising candidate for further exploitation as a potential drug
target to disrupt the essential mycolyl-arabinogalactan-peptidoglycan
complex in mycobacterial species, such asM. tuberculosis.
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